logo
AI Icon𝛼SK or Search
ENTITY

MetaVia (MTVA US)

24
Analysis
Health Care • United States
MetaVia Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing dual oxyntomodulin (OXM) analog agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). MetaVia serves customers worldwide.
more
Company Presentation • 01 Aug 2026 20:00

Investor presentation

Company Presentation • 14 May 2026 19:00

Investor presentation

Company Presentation • 26 Mar 2026 19:00

Investor presentation

Company Presentation • 27 Mar 2026 04:00

Investor presentation

Company Presentation • 15 Apr 2025 19:00

Investor Presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x